Company intelligence / Profile preview

Vitaltes

Ownership: Private
Development stage: Other

Overview

Vitaltes is an emerging biotechnology company focused on developing innovative therapies to address aging-related diseases and metabolic disorders. The company leverages a proprietary platform centered on mitochondrial health and cellular rejuvenation to identify novel drug candidates. Vitaltes aims to restore cellular function and improve healthspan by targeting key metabolic pathways that decline with age. Their current research efforts are primarily in the pre-clinical stage, focusing on neurodegeneration and systemic metabolic health.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Vitaltes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitaltes.

Explore the full profile